Fludroxycortide
From Wikipedia, the free encyclopedia
Fludroxycortide
|
|
Systematic (IUPAC) name | |
6-fluoro-11,21 dihydroxy-16,17- [(l-methylethylidene) bis (oxy)]-, (6?, 11?, 16?)- Pregn-4-ene-3,20-dione | |
Identifiers | |
CAS number | |
ATC code | D07 |
PubChem | |
DrugBank | |
Chemical data | |
Formula | C24H33FO6 |
Mol. mass | 436.514 g/mol |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | ? |
Half life | ? |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status | |
Routes | ? |
Please help improve this article or section by expanding it. Further information might be found on the talk page or at requests for expansion. (January 2007) |
Fludroxycortide (INN; also known as flurandrenolone or flurandrenolide ) is a synthetic steroid and is used as an anti-inflammatory treatment for use on skin irritations.
Licensed indications in the United Kingdom include "recalcitrant dermatoses".
Fludroxycortide is available in ointment, cream and as an impregnated blenderm tape. (Haelan tape (Typharm Ltd), Cordran tape)
[edit] References
This article does not cite any references or sources. (November 2007) Please help improve this article by adding citations to reliable sources. Unverifiable material may be challenged and removed. |